Japanese panel delays verdict on Shionogi’s COVID pill until July

0
4

A Health Ministry panel postponed a decision on Wednesday on whether to grant Shionogi’s COVID-19 pill emergency approval, citing the need for further discussion.

The oral drug, which is the first domestically developed COVID-19 treatment and is intended for use in patients with mild to moderate symptoms, had been evaluated by the panel after the Osaka-based pharmaceutical company applied for approval. under the emergency authorization system. created in May.

.

LEAVE A REPLY

Please enter your comment!
Please enter your name here